IP Library › Granted Patent US 7,871,794
Granted Patent B2
US 7,871,794 · App. 12/016,763 · Granted Jan 18, 2011

Enhanced cell-free synthesis of active proteins containing disulfide bonds

Assignee: The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,871,794
App. No.
12/016,763
Granted
Jan 18, 2011
Kind
B2
Abstract

Compositions and methods are provided for the enhanced in vitro synthesis of active polypeptides containing disulfide bonds. In certain embodiments of the invention, the reaction mix includes a biological extract derived from a bacterial cell in which the glutathione reductase gene has been inactivated, which is pre-treated with a low concentration of a sulfhydryl inactivating agent.

Claims (24)

1. A method for cell-free synthesis of properly folded polypeptides comprising at least one disulfide bond, the improvement comprising:

synthesizing said polypeptide in a reaction mix comprising a biological extract derived from a bacterial cell that has been genetically modified to inactivate glutathione reductase and pre-treated with low concentrations of a sulfhydryl inactivating agent;

wherein the low concentration of the sulfhydryl inactivating agent is equivalent in sulfhydryl inactivating activity to iodoacetamide at a concentration of from 10 μM to about 100 μM.

2. The method according to claim 1 , wherein said sulfhydryl inactivating agent alkylates or acetylates free sulfhydryl groups.

3. The method of claim 2 , wherein the sulfhydryl inactivating agent is iodoacetamide.

4. The method according to claim 1 , wherein the biological extract is treated to remove thioredoxin reductase.

5. The method according to claim 4 , wherein the bacterial cell from which the biological extract is derived is genetically modified such that said thioredoxin reductase protein comprises an affinity tag; and the treatment to remove the thioredoxin reductase comprises contacting the biological extract with an affinity resin specific for the affinity tag.

6. The method according to claim 1 , wherein said reaction mix comprises an energy source lacking high energy phosphate bonds at a concentration of at least about 50 mM.

7. The method according to claim 6 , wherein said energy source is glucose or a glycolytic intermediate lacking high energy phosphate bonds.

8. The method according to claim 1 , wherein said reaction mix further comprises a redox buffer.

9. The method according to claim 8 , wherein said redox buffer comprises one or more of glutathione, cysteine, and homocysteine.

10. The method according to claim 9 , wherein said redox buffer comprises a mixture of oxidized and reduced glutathione.

11. The method according to claim 1 , wherein said reaction mixture comprises one or more enzymes that enhance polypeptide folding or generation of disulfide bonds.

12. The method according to claim 11 , wherein said one or more enzymes that enhance polypeptide folding or generation of disulfide bonds are foldase enzymes.

13. The method according to claim 1 , wherein said reaction mixture is substantially free of polyethylene glycol.

14. The method according to claim 13 , wherein said reaction mixture comprises one or more of spermine, spermidine and putrescine.

15. A reaction mix for cell-free protein translation, comprising a biological extract derived from a bacterial cell that has been genetically modified to inactivate glutathione reductase and pre-treated with low concentrations of a sulfhydryl inactivating agent;

wherein the low concentration of the sulfhydryl inactivating agent is equivalent in sulfhydryl inactivating activity to iodoacetamide at a concentration of from 10 μM to about 100 μM.

16. The reaction mix according to claim 15 , wherein said sulfhydryl inactivating agent alkylates or acetylates free sulfhydryl groups.

17. The method of claim 16 , wherein the sulfhydryl inactivating agent is iodoacetamide.

18. The reaction mix according to claim 15 , wherein said biological extract is treated to remove thioredoxin reductase.

19. The reaction mix according to claim 18 , wherein the bacterial cell from which the biological extract is derived is genetically modified such that said thioredoxin reductase protein comprises an affinity tag; and the treatment to remove the thioredoxin reductase comprises contacting the biological extract with an affinity resin specific for the affinity tag.

20. The reaction mix according to claim 15 , wherein said reaction mix comprises an energy source lacking high energy phosphate bonds, at a concentration of at least about 50 mM.

21. The reaction mix according to claim 20 , wherein said energy source is glucose or a glycolytic intermediate lacking high energy phosphate bonds.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 28, 2009
From: STANFORD UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 023014/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2008
From: KNAPP, KURTIS G.; SWARTZ, JAMES ROBERT
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 021144/0822 →
Continuity (2)
Provisional Application 6088125100 · Jan 18, 2007
Related Publication 20080248521A1 · Oct 9, 2008